Provided by Tiger Trade Technology Pte. Ltd.

ARCELLX, INC.

114.57
-0.0500-0.04%
Post-market: 114.570.00000.00%19:11 EDT
Volume:1.65M
Turnover:189.59M
Market Cap:6.70B
PE:-28.15
High:114.82
Open:114.62
Low:114.54
Close:114.62
52wk High:114.91
52wk Low:47.86
Shares:58.48M
Float Shares:39.70M
Volume Ratio:0.89
T/O Rate:4.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0700
EPS(LYR):-4.0700
ROE:-53.42%
ROA:-24.05%
PB:16.65
PE(LYR):-28.15

Loading ...

Arcellx shareholders set to receive USD 115 per share in Gilead deal

Reuters
·
Mar 17

Gilead Sciences to Buy Arcellx for $115 a Share Plus $5 CVR

Reuters
·
Mar 06

Truist Financial Keeps Their Hold Rating on Arcellx Inc (ACLX)

TIPRANKS
·
Mar 02

Arcellx Inc : TD Cowen Cuts to Hold From Buy

THOMSON REUTERS
·
Mar 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Alkermes (ALKS) and Progyny (PGNY)

TIPRANKS
·
Mar 02

U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, CrowdStrike

Reuters
·
Mar 02

Arcellx (ACLX) Posts US$228.9m TTM Loss Testing Bullish Profitability Narratives

Simply Wall St.
·
Feb 28

Arcellx FY 2025 collaboration revenue falls 79% to USD 22.3 million

Reuters
·
Feb 27

Arcellx Cut to Neutral From Buy by Guggenheim

Dow Jones
·
Feb 27

Guggenheim Downgrades Arcellx to Neutral From Buy, Adjusts PT to $115 From $120

MT Newswires Live
·
Feb 26

U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite

Reuters
·
Feb 26

Gilead FY 2025 net income attributable to shareholders hits USD 8.5 billion (NM)

Reuters
·
Feb 25

Arcellx Inc : UBS Cuts to Neutral From Buy

THOMSON REUTERS
·
Feb 24

Arcellx Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
Feb 24

RPT-BREAKINGVIEWS-An $8 bln pharma deal prices patent fears

Reuters
·
Feb 24

Arcellx Inc : Wells Fargo Cuts to Equal Weight From Overweight; Raises Target Price to $115 From $100

THOMSON REUTERS
·
Feb 24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (ACLX) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

TIPRANKS
·
Feb 24

Arcellx downgraded to In Line from Outperform at Evercore ISI

TIPRANKS
·
Feb 24

Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)

TIPRANKS
·
Feb 24

Arcellx rises 77.6%

TIPRANKS
·
Feb 24